Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Advanced Desmoid Tumor × Imatinib Mesylate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gastrointestinal Stromal Tumors 5 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Histiocytoma, Malignant Fibrous 2 Fibrosarcoma 2 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Neoplasm, Residual 1 Malignant mesenchymal tumor 1 Liposarcoma 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Leiomyosarcoma 1 Hemangiosarcoma 1 Hemangiopericytoma, Malignant 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Burkitt Lymphoma 1

Interventions

Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00928525 2023-10-05

Basket 1

Italian Sarcoma Group

Phase 2 Completed

Advanced Desmoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡